ITI: N-[3-(5-{2-[(4-morpholin-4-ylphenyl)amino]pyrimidin-4-yl}imidazo[2,1-b][1,3]thiazol-6-yl)phenyl]-2-phenylacetamide
ITI is a Ligand Of Interest in 3LZB designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3LZB_ITI_B_1 | 93% | 19% | 0.074 | 0.975 | 1.43 | 1.94 | 3 | 18 | 18 | 0 | 100% | 1 |
| 3LZB_ITI_A_1 | 92% | 23% | 0.072 | 0.969 | 1.16 | 1.91 | 4 | 15 | 24 | 0 | 100% | 1 |
| 3LZB_ITI_D_1 | 72% | 39% | 0.117 | 0.944 | 0.94 | 1.32 | 4 | 6 | 25 | 0 | 100% | 1 |
| 3LZB_ITI_C_1 | 64% | 27% | 0.135 | 0.936 | 1.1 | 1.73 | 4 | 16 | 18 | 0 | 100% | 1 |
